2 results match your criteria: "Cancer Institute of New Jersey at Cooper University Hospital[Affiliation]"
Changes in smoking associated with an acute health event: theoretical and practical implications.
Ann Behav Med
April 2007
Department of Emergency Medicine, UMDNJ-Robert Wood Johnson Medical School and Cancer Institute of New Jersey at Cooper University Hospital, Camden, New Jersey 08103, USA.
Background: Experiencing a serious adverse behavior-related consequence may motivate behavior change.
Purpose: To examine how a sentinel health event is associated with changes in smoking.
Methods: We used a prospective cohort design.
Response to temozolomide in second-line treatment of recurrent nonsmall cell lung carcinoma: case report.
Cancer Invest
April 2005
Division of Hematology/Oncology, Cancer Institute of New Jersey at Cooper University Hospital, Camden, New Jersey 08103, USA.
Almost all patients with stage IV nonsmall cell lung cancer (NSCLC) who show an initial response to chemotherapy will eventually relapse. For patients with a good performance status at relapse, second-line chemotherapy is a standard treatment option. A case of recurrent NSCLC described herein profiles a patient previously treated with cisplatin, irinotecan, and radical thoracic radiation for stage IIIb NSCLC.
View Article and Find Full Text PDF